Evidence map›Paper›PMID 29463682›Full record

ReviewThe Journal of biological chemistry2019

Metabolism in pluripotency: Both driver and passenger?

Perrine Dahan, Vivian Lu, Robert M T Nguyen, Stephanie A L Kennedy, Michael A Teitell

Abstract readReview
In one paragraph

Review in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Hereditary spastic paraplegia: from decades of therapy to future innovations.Therapeutic advances in neurological disorders · 2026
    Review
  6. Lactate promotes H3K18 lactylation in human neuroectoderm differentiation.Cellular and molecular life sciences : CMLS · 2024
    Article
  7. Article
  8. Review
  9. The role of lipids in genome integrity and pluripotency.Biochemical Society transactions · 2024
    Review
  10. Review
  11. "Time Is out of Joint" in Pluripotent Stem Cells: How and Why.International journal of molecular sciences · 2024
    Review
  12. Article
  13. Monitoring ADSC Metabolism Using the Seahorse Analyzer.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Role of the Mitochondrial Permeability Transition in Bone Metabolism and Aging.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Perrine DahanFrom the Departments of Pathology and Laboratory Medicine and.
Vivian LuMolecular and Medical Pharmacology and.
Robert M T NguyenFrom the Departments of Pathology and Laboratory Medicine and.
Stephanie A L KennedyFrom the Departments of Pathology and Laboratory Medicine and.
Michael A TeitellFrom the Departments of Pathology and Laboratory Medicine and mteitell@mednet.ucla.edu.

Funding

RNA trafficking in mitochondriaR01GM073981 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Carla M Koehler, MICHAEL A TEITELL · 2006 to 2026
$5.1M
TCL1 ONCOGENE IN B LYMPHOCYTE DEVELOPMENT AND NEOPLASIAR01CA090571 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TEITELL, MICHAEL A · 2002 to 2015
$3.8M
(PQD5) Mass Profiling Melanoma Responses to Improve Therapy Choices and PrognosisR01CA185189 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI REED, JASON C, TEITELL, MICHAEL A · 2014 to 2017
$1.9M
Reverse Mitochondrial Genetics Enabled by BlastR01GM114188 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHIOU, PEI-YU, TEITELL, MICHAEL A · 2015 to 2018
$1.9M
(PQ5) Mitochondrial Transfer in Tumor Heterogeneity and Acquired Resistence to TherapyR21CA227480 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TEITELL, MICHAEL A · 2019 to 2020
$373k
Role of pH on Lineage Fate during Pluripotent Stem Cell DifferentiationF31HD097960 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LU, VIVIAN · 2019 to 2021
$112k
NCI NIH HHS R01 CA090571NCI NIH HHS R01 CA185189NCI NIH HHS R21 CA227480NICHD NIH HHS F31 HD097960NIGMS NIH HHS R01 GM073981NIGMS NIH HHS R01 GM114188
6 · The paper itself

Abstract

Pluripotent stem cells (PSCs) are highly proliferative cells characterized by robust metabolic demands to power rapid division. For many years considered a passive component or "passenger" of cell-fate determination, cell metabolism is now starting to take center stage as a driver of cell fate outcomes. This review provides an update and analysis of our current understanding of PSC metabolism and its role in self-renewal, differentiation, and somatic cell reprogramming to pluripotency. Moreover, we present evidence on the active roles metabolism plays in shaping the epigenome to influence patterns of gene expression that may model key features of early embryonic development.

Indexed as

AnimalsCell DifferentiationCell ProliferationEpigenesis, GeneticHumansPluripotent Stem Cellscell fatedifferentiationepigeneticsmetabolismmitochondriapluripotencyreprogrammingstem cells

Identifiers

PMID29463682
PMCPMC6462533

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.